Park Avenue Securities LLC Bristol Myers Squibb CO Transaction History

Park Avenue Securities LLC

$9.72 Billion
Q4 2024

A detailed history of Park Avenue Securities LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Park Avenue Securities LLC holds 56,806 shares of BMY stock, worth $3.24 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

56,806

Previous 42,854 32.56%

Holding current value

$3.24 Million

Previous $2.22 Million 44.93%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$51.92 - $59.94 $724,387 - $836,282	13,952 Added 32.56%	56,806 $3.21 Million
Q3 2024 Oct 03, 2024	SELL	$39.66 - $51.75 $63,019 - $82,230	-1,589 Reduced 3.58%	42,854 $2.22 Million
Q2 2024 Jul 09, 2024	SELL	$40.25 - $52.99 $324,737 - $427,523	-8,068 Reduced 15.36%	44,443 $1.85 Million
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $593,176 - $672,547	12,363 Added 30.79%	52,511 $2.85 Million
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $516,408 - $616,218	-10,652 Reduced 20.97%	40,148 $2.06 Million
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $61,537 - $68,807	1,063 Added 2.14%	50,800 $2.95 Million
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $395,002 - $438,587	-6,200 Reduced 11.08%	49,737 $3.18 Million
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $679,638 - $770,863	10,343 Added 22.69%	55,937 $3.88 Million
Q4 2022 Jan 24, 2023	BUY	$68.48 - $81.09 $597,761 - $707,834	8,729 Added 23.68%	45,594 $0
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $295 - $174,657	2,273 Added 6.57%	36,865 $2.62 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $109,365 - $120,449	1,506 Added 4.55%	34,592 $2.66 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $804,035 - $964,110	13,078 Added 65.36%	33,086 $2.42 Million
Q4 2021 Apr 08, 2022	BUY	$53.63 - $62.52 $177,783 - $207,253	3,315 Added 19.86%	20,008 $1.25 Million
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $382,711 - $448,297	-6,468 Reduced 27.93%	16,693 $988,000
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $472,001 - $514,010	-7,624 Reduced 24.77%	23,161 $1.55 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $215,107 - $241,932	-3,625 Reduced 10.53%	30,785 $1.94 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $92,384 - $104,688	1,600 Added 4.88%	34,410 $2.13 Million
Q3 2020 Nov 03, 2020	BUY	$57.43 - $63.64 $129,906 - $143,953	2,262 Added 7.4%	32,810 $1.98 Million
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $1.67 Million - $1.96 Million	30,548 New	30,548 $1.8 Million
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $819,702 - $1.19 Million	-17,666 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $214,506 - $279,804	4,359 Added 32.76%	17,666 $1.13 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $569,140 - $674,797	13,307 New	13,307 $675,000
Q2 2019 Jul 26, 2019	SELL	$44.62 - $49.34 $464,404 - $513,530	-10,408 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $469,608 - $559,950	10,408 New	10,408 $490,000

Others Institutions Holding BMY

# of Institutions

2,555

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Bristol Myers Squibb CO Transaction History